Perez-Vega, Carlos
Ramos-Fresnedo, Andres
Tripathi, Shashwat
Domingo, Ricardo A.
Ravindran, Krishnan
Almeida, Joao P.
Peterson, Jennifer
Trifiletti, Daniel M.
Chaichana, Kaisorn L.
Quinones-Hinojosa, Alfredo
Samson, Susan L. http://orcid.org/0000-0002-8159-7093
Article History
Accepted: 9 March 2022
First Online: 4 May 2022
Declarations
:
: Susan L. Samson has been a site principal investigator for clinical trials involving patients with Cushing’s disease for Novartis and Corcept. The remaining authors have no relevant financial or non-financial interest to disclose.
: This is a meta-analysis; no ethical approval or informed consent was required by the institutional review board.